Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

ACRSACRS
Showing 7 of 24 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in ACLARIS THERAPEUTICS INC

JANE STREET GROUP, LLC previously held 0 shares of ACRS (ACLARIS THERAPEUTICS INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$95,136

Total Shares Change

-82,727

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$3.04
0
2025-Q4
Decreased
27,216
-62.8%
$81,9200.0%$2.90
0
2025-Q3
New
73,113
-
$138,9150.0%$1.92
34
2025-Q2
Exited
0
-100.0%
$00.0%$1.47
0
2025-Q1
Decreased
390,282
-28.5%
$597,1310.0%$1.59
0
2024-Q4
Increased
545,564
+559.5%
$1.4M0.0%$2.48
41
2024-Q3
Decreased
82,727
-75.3%
$95,1360.0%$1.17
0

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used